About 100 reports

  • Description of Brain Cancer Types
  • 3.5.1 Diagnosed Incident Cases of Brain Cancer

Table ## presents a description of the different types of brain cancer presented in this report.

  • Brain Cancer
  • United Kingdom
  • United States
  • World
  • Forecast

You can request one free hour of our analyst’s time when you purchase this market report.

  • Brain Cancer
  • World
  • Market Size

Global Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Forecast

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • France
  • United States
  • Market Size

Europe Brain Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Brain Cancer
  • Europe
  • France
  • Germany
  • Forecast

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • France
  • Germany
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

Brain Cancer Phase ## Clinical Trials, 2016 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size

Brain Tumor Therapeutics: Global Markets to 2023 Chapter ## Introduction Scope of Report Study Goals and Objectives Reasons for Doing This Study Information Sources and Methodology Geographic Breakdown Analyst’s Credentials BCC Custom Research Related BCC Research Reports Chapter ##

  • Brain Cancer
  • Therapy
  • World
  • DESCRIPTION OF BRAIN CANCER TYPES
  • 5.5 EPIDEMIOLOGICAL FORECAST FOR BRAIN CANCER (2017-2027)

THE DIFFERENCES IN THE FIVE-YEAR DIAGNOSED PREVALENT CASES OF BRAIN CANCER AMONG THE ##MM ARE DEPENDENT ON THE MARKET-SPECIFIC ONE- TO FIVE-YEAR OBSERVED SURVIVAL PROPORTIONS AND THE INCIDENCE RATE OF BRAIN CANCER.

  • Brain Cancer
  • China
  • United States
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)
  • Market Size

BRAIN CANCER IS THE LEADING CAUSE OF CANCER-RELATED Chapter III BRAIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS DEATH IN PATIENTS YOUNGER THAN AGE ##.

  • Brain Cancer
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • Brain Cancer Treatment Drugs Sales Volume
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2017(percent)

SOME BRAIN CANCERS OCCUR WHEN ONE TYPE OF CELL TRANSFORMS FROM ITS NORMAL CHARACTERISTICS.

  • Brain Cancer
  • Demand
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Chapter IV
  • Pricing Trend

Some brain cancers occur when one type of cell transforms from its normal characteristics.

  • Brain Cancer
  • Demand
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Beijing Novartis Pharma Ltd

Increasing prevalence of cancer, brain tumours, and renal cell cancer will boost the market growth.

  • Brain Cancer
  • North America
  • United States
  • World
  • Guerbet Group
  • TOP COMPANIES PARTICIPATING IN BRAIN CANCER THERAPEUTICS CLINICAL TRIALS
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS

Brain Cancer Global Clinical Trials Review, H##, 2018 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2018 LIST OF TABLES LIST OF FIGURES Brain Cancer Global Clinical Trials Review, H##, 2018 outlines clinical trials in Brain

  • Brain Cancer
  • Clinical Trial
  • Oncology
  • United States
  • World
  • LATEST CLINICAL TRIALS NEWS ON BRAIN CANCER
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS

Brain Cancer Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2017 LIST OF TABLES LIST OF FIGURES Brain Cancer Global Clinical Trials Review, H##, 2017 outlines clinical trials in Brain

  • Brain Cancer
  • Cancer
  • United States
  • World
  • Product Initiative
  • APR 11, 2017: FEINSTEIN INSTITUTE EXAMINES USE OF ANTIPARASITIC DRUG AS NEW TREATMENT FOR BRAIN TUMORS
  • APR 11, 2017: FEINSTEIN INSTITUTE EXAMINES USE OF AN ANTIPARASITIC DRUG AS NEW TREATMENT FOR BRAIN TUMORS

This agreement enables Novogen and Feinstein Institute to provide treatments for brain cancer.

  • Brain Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Social Conditions

Strategic initiatives List of Tables ##.

  • Brain Cancer
  • Therapy
  • United States
  • Forecast
  • Market Size

Brain Cancer Pipeline Highlights – 2017 ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Product Initiative
  • 18.1 Competitive Scenario
  • 05. Introduction

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Brain Cancer
  • Arbor Pharmaceuticals, LLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • NANOTHERM - BRAIN CANCER
  • NANOTHERM - BRAIN CANCER PRODUCT OVERVIEW

Cancer ## Glioblastoma Multiforme ## Pancreatic Cancer ## Prostate Cancer ## Prostate Carcinoma ## Stomach Neoplasm ## Brain Cancer ## MagForce AG Ongoing Clinical Trials by Trial Status Ongoing, Recruiting

  • Brain Cancer
  • Prostate Cancer
  • Germany
  • United States
  • MagForce AG
  • JUN 13, 2018: IMMUNOTHERAPY VACCINE SHOWS GREAT PROMISE IN TREATING BRAIN CANCER PATIENTS
  • MAY 29, 2018: INTERIM RESULTS FROM CLINICAL TRIAL OF IMMUNOTHERAPY FOR GLIOBLASTOMA SHOW SIGNIFICANT CLINICAL BENEFIT

Stemline Therapeutics is developing SL-## for the treatment of brain cancer.

  • Brain Cancer
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Immunovaccine Inc.
  • Oct 12, 2017: Lenox Hill Hospital participates in clinical research study to test investigational treatment for recurrent brain cancer

Its pipeline products include CX-## a proprietary combination of disulfiram and copper that is in Phase II clinical trial for the treatment of recurrent glioblastoma; and completed Phase ## trial in metastatic prostate cancer and breast cancer.

  • Brain Cancer
  • United States
  • Deals & Alliance
  • Product Initiative
  • Cantex Pharmaceuticals, Inc.
  • Sep 26, 2016: Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
  • Nov 27, 2017: Cancer drug starts clinical trials in human brain-cancer patients

Its TVI-Brain-## is a drug therapy used for the treatment of brain cancer.

  • Brain Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • 06/05/2018: Personalized vaccine may increase long-term survival in people with deadliest form of brain cancer
  • Jun 05, 2017: Dr. Marnix Bosch To Present Update on DCVax-L at the ASCO Conference

It is the largest trial to date testing a customized vaccine in people diagnosed with brain cancer.

  • Brain Cancer
  • Medical Biotechnology
  • United States
  • Corporate Finance
  • Northwest Biotherapeutics, Inc.